Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
Madrona
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Terray TherapeuticsSeries B $120M · 23 mo ago • 51-200 employees • 3 roles
The only integrated full-stack AI platform for small molecule drug discovery.
By testing every gene across all human tissues using large-scale Mendelian randomization and colocalization across thousands of diseases…
TurbineVenture round $121M · 17 mo ago • 201-500 employees • 3 roles
Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
insitroVenture round $143M · 6 yr ago • Founded 2018 • 51-200 employees • 13 roles
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets…
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
Mirror PhysicsFounded 2024 • 1-10 employees • 2 roles
Axon is an interactive AI platform that accelerates drug discovery by amplifying the utility of cheminformatics, physics-based simulation…

Overview

AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and accelerate drug development.

News

News NBC Boston 29 days ago
MIT student claims to synthesize dangerous chemical, prompting hazmat response
The situation started when a graduate student arrived at a local emergency room saying they had synthesized dimethyl mercury, a hazardous chemical, while...
Read more
Report
News blog.nathanlangley.dev 4 months ago
How synthesize_capability works - NinjaHawk's Nest Read more
Report
News synthesizebio.substack.com 5 months ago
GEM-1 Predicts Clinical Trial Response
A virtual human modeling + immune checkpoint blockade case study
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.